|
|||||
|
|
OnabotulinumtoxinA for chronic migraine: efficacy,safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program |
|
| Authors: | S. K. Aurora D. W. Dodick H.‐C. Diener R. E. DeGryse C. C. Turkel R. B. Lipton S. D. Silberstein |
| Affiliation: | 1. Stanford University, , Stanford, CA, USA;2. Mayo Clinic Arizona, , Phoenix, AZ, USA;3. University of Essen, , Essen, Germany;4. Allergan, Inc., , Irvine, CA, USA;5. Albert Einstein College of Medicine, , Bronx, NY, USA;6. Thomas Jefferson University, , Philadelphia, PA, USA |
| Abstract: | |
| Keywords: | chronic migraine headache long term onabotulinumtoxinA PREEMPT prophylaxis |